Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
AstraZeneca PLC second quarter and half year results 2013
-
AstraZeneca and FibroGen collaborate to develop and commercialise FG-4592, a treatment for anaemia in chronic kidney disease and end-stage renal disease
-
AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application for the treatment of type 2 diabetes in the U.S
-
US FDA acknowledges receipt of resubmission of the New Drug Application for investigational compound dapagliflozin for the treatment of type 2 diabetes
-
Simon Lowth, Chief Financial Officer, to leave AstraZeneca
-
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
-
AstraZeneca Completes Acquisition Of Pearl Therapeutics
-
AstraZeneca and Bristol-Myers Squibb announce top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
-
AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK
-
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
Latest articles and press releases
All of our latest press releases and articles are available to explore
